Merck's $5.7 Billion Diabetes Franchise Vulnerable
A retrospective analysis published by the BMJ supports previously published findings that diabetic patients taking drugs which target the incretin system to control their blood sugars are at greater...
View ArticleNew Drug May Someday Battle Obesity and Diabetes – WebMD
New Drug May Someday Battle Obesity and Diabetes By Dennis Thompson HealthDay Reporter WEDNESDAY, Oct. 30 (HealthDay News) — A new diabetes drug may one day perform double duty for patients,...
View Article
More Pages to Explore .....
